On Tuesday, Tango Therapeutics Inc (NASDAQ: TNGX) was 7.97% up from the session before settling in for the closing price of $1.38. A 52-week range for TNGX has been $1.11 – $12.02.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 103.26% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at -17.02%. With a float of $59.12 million, this company’s outstanding shares have now reached $107.73 million.
In an organization with 155 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 97.01%, operating margin of -346.08%, and the pretax margin is -309.23%.
Tango Therapeutics Inc (TNGX) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Tango Therapeutics Inc stocks. The insider ownership of Tango Therapeutics Inc is 45.31%, while institutional ownership is 56.02%. The most recent insider transaction that took place on Feb 04 ’25, was worth 8,289. In this transaction General Counsel of this company sold 2,774 shares at a rate of $2.99, taking the stock ownership to the 68,570 shares. Before that another transaction happened on Feb 05 ’25, when Company’s General Counsel sold 2,556 for $3.16, making the entire transaction worth $8,081. This insider now owns 66,014 shares in total.
Tango Therapeutics Inc (TNGX) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.35 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -17.02% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -10.41% during the next five years compared to 7.47% growth over the previous five years of trading.
Tango Therapeutics Inc (NASDAQ: TNGX) Trading Performance Indicators
You can see what Tango Therapeutics Inc (TNGX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 6.98. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.83.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.20, a number that is poised to hit -0.35 in the next quarter and is forecasted to reach -1.41 in one year’s time.
Technical Analysis of Tango Therapeutics Inc (TNGX)
Let’s dig in a bit further. During the last 5-days, its volume was 0.46 million. That was inferior than the volume of 0.76 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 69.17%. Additionally, its Average True Range was 0.16.
During the past 100 days, Tango Therapeutics Inc’s (TNGX) raw stochastic average was set at 12.26%, which indicates a significant decrease from 95.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 111.36% in the past 14 days, which was higher than the 85.37% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.8250, while its 200-day Moving Average is $5.2487. However, in the short run, Tango Therapeutics Inc’s stock first resistance to watch stands at $1.5467. Second resistance stands at $1.6033. The third major resistance level sits at $1.7067. If the price goes on to break the first support level at $1.3867, it is likely to go to the next support level at $1.2833. The third support level lies at $1.2267 if the price breaches the second support level.
Tango Therapeutics Inc (NASDAQ: TNGX) Key Stats
There are 108,108K outstanding shares of the company, which has a market capitalization of 161.08 million. As of now, sales total 42,070 K while income totals -130,300 K. Its latest quarter income was 4,120 K while its last quarter net income were -37,670 K.
